Merck Sharp & Dohme Corp. v. Watson Laboratories, Inc. et al
| Merck Sharp & Dohme Corp. |
| Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. and Teva Pharmaceutical Industries, Ltd. |
| 1:2019cv00317 |
| February 13, 2019 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 12, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Keith A. Zullow, Emily L. Rapalino, Julius Jefferson, and Christie Larochelle - filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Gattuso, Dominick) |
Filing 11
STIPULATION and Order to Extend Time, by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Gattuso, Dominick) Modified on 4/12/2019 (nms).
|
| Filing 10 NOTICE of Appearance by Dominick T. Gattuso on behalf of Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (Gattuso, Dominick) |
|
SO ORDERED, re #11 Stipulation and Order to Extend Time (*Reset Answer Deadlines: Watson Laboratories, Inc. answer due 4/30/2019). Signed by Judge Richard G. Andrews on 4/12/2019. (nms)
|
|
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Keith A. Zullow, Emily L. Rapalino, Julius Jefferson, and Christie Larochelle, filed by Teva Pharmaceutical Industries, Ltd., Watson Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 4/12/2019. (nms)
|
| Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ddp) |
| Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) |
| Pro Hac Vice Attorney Jingyuan Luo for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) |
|
SO ORDERED, re (6 in 19-cv-321-RGA, 6 in 19-cv-318-RGA, 6 in 19-cv-312-RGA, 6 in 19-cv-314-RGA, 6 in 19-cv-310-RGA, 6 in 19-cv-316-RGA, 6 in 19-cv-313-RGA, 6 in 19-cv-320-RGA, 6 in 19-cv-347-RGA, 6 in 1:19-cv-00319-RGA, 6 in 19-cv-317-RGA, 6 in 19-cv-311-RGA, 6 in 19-cv-315-RGA) MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jinyuan Luo, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 2/22/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00310-UNA et al.(bkb) |
| Filing 9 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Watson Laboratories, Inc. waiver sent on 2/15/2019, answer due 4/16/2019. (Silver, Daniel) |
| Filing 8 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Teva Pharmaceuticals USA, Inc. waiver sent on 2/15/2019, answer due 4/16/2019. (Silver, Daniel) |
| Filing 7 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Teva Pharmaceutical Industries, Ltd. waiver sent on 2/15/2019, answer due 4/16/2019. (Silver, Daniel) |
| Filing 6 MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certifications)(Silver, Daniel) Modified on 2/22/2019 (nms). |
| Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries, Ltd. on 2/14/2019; Teva Pharmaceuticals USA, Inc. on 2/14/2019; Watson Laboratories, Inc. on 2/14/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (nmg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,3026,708; 8,414,921. (nmg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached. (nmg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2569897.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
